| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.265 | 28.911 | - | 24.121 | 20.129 | 23.829 | 69.847 | 48.110 | 64.368 | 40.845 |
| Total Income - EUR | 38.616 | 28.918 | - | 24.125 | 20.134 | 23.832 | 69.857 | 48.119 | 64.873 | 40.860 |
| Total Expenses - EUR | 24.778 | 24.288 | - | 16.165 | 14.843 | 13.400 | 17.139 | 22.531 | 29.333 | 29.873 |
| Gross Profit/Loss - EUR | 13.838 | 4.631 | - | 7.959 | 5.290 | 10.432 | 52.719 | 25.588 | 35.539 | 10.986 |
| Net Profit/Loss - EUR | 12.679 | 4.342 | - | 7.718 | 5.089 | 10.212 | 52.020 | 25.107 | 34.890 | 10.578 |
| Employees | 3 | 3 | - | 2 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Oxivet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 32.672 | 40.839 | - | 39.899 | 38.879 | 44.240 | 46.423 | 47.714 | 56.380 | 59.533 |
| Current Assets | 22.206 | 4.010 | - | 13.559 | 9.647 | 11.522 | 32.347 | 23.260 | 38.544 | 11.073 |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.036 | 1.015 | - | 3.695 | 2.951 | 221 | 4.555 | 3.767 | 814 | 4.348 |
| Cash | 19.170 | 2.994 | - | 9.864 | 6.696 | 11.300 | 27.791 | 19.493 | 37.730 | 6.725 |
| Shareholders Funds | 17.988 | 9.597 | - | 12.789 | 10.062 | 15.091 | 56.791 | 29.892 | 39.661 | 15.322 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 36.889 | 35.253 | - | 40.669 | 38.464 | 40.671 | 21.979 | 41.081 | 55.263 | 55.284 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Oxivet S.r.l.